Abstract
The endocannabinoid system (EC) of cell signaling regulates bone homeostasis, and activation of its CB2 receptor has been associated with the inhibition of bone resorption and increased bone formation, making it a potential therapeutic target for osteoporosis and other osteometabolic diseases. These sistemic diseases affect the orthodontic tooth movement (OTM). Thus, the aim of the prese…